Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-21-000006

President and CEO sold 24,132 shares at an average $110.03 ($2,655,177)

  • President and CEO acquired 24,132 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kramer Robert · President and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-20 Exercise or conversion : show line 1 in the form +2,232 $26.45 $59,036 141,442 D
2021-01-20 Sale : show line 2 in the form −2,232 $110.00 $245,520 139,210 D
2021-01-21 Exercise or conversion : show line 3 in the form +21,900 $26.45 $579,255 161,110 D
2021-01-21 Sale : show line 4 in the form −21,900 $110.03 $2,409,657 139,210 D
Open-market sales · 24,132 sh · avg $110.03 · $2,655,177

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-20 Exercise or conversion : show line 5 in the form Employee Stock Options (Right to Buy) −2,232 $110.00 $245,520 21,900 D
2021-01-21 Exercise or conversion : show line 6 in the form Employee Stock Options (Right to Buy) −21,900 $110.03 $2,409,657 0 D
Loading xslF345X03/wf-form4_161135005224162.xml…